SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

Share Price is delayed by 15 minutes
Get Live Data
3.75    0.00 (0.00%)
Bid:
3.50
Ask:
4.00
Spread: 0.50 (14.286%)
Market Cap: £1.19m
SNT Live PriceLast checked at - London Stock Exchange

Intraday Sabien Tech. Share Chart

Proton Technologies

26 Sep 2023 07:00

RNS Number : 5869N
Sabien Technology Group PLC
26 September 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.

26 September 2023

 

Sabien Technology Group plc

("Sabien", the "Company" or the "Group")

 

Proton Technologies

 

Sabien Technology Group plc (AIM:SNT), the company focused on a green aggregation strategy, today announces that it has reviewed the value of its investment in Proton Technologies Canada Inc., ("Proton") following the proposed investment in and restructuring of Proton. 

 

On 14 October 2021, Sabien invested £100,000 in Proton, giving the Company a 0.08% shareholding. Subsequently, Sabien entered into a licensing agreement with Proton on 1 February 2022. This agreement allowed Sabien to deploy Proton's technology within the UK and the right to install a plant for the City Oil Field, Inc. plastic to oil technology on Proton's Saskatchewan site. Sabien retains the rights conferred by this licensing agreement.

 

On 8 September 2023, Proton informed its shareholders that it had received a proposal from a third party to inject new capital, restructure its balance sheet, and reform its management team (the "Proposal"). The Proposal remains subject to shareholder approval.

 

Following a review of the Proposal and ahead of approval by Proton shareholders, the Board of Sabien has concluded that the value of the Company's stake (£100,000) may require a material impairment provision in the accounts for the financial year to 30 June 2023. The Board expects that this provision will allow for a potential material diminution in the value of existing Proton equity to reflect the notional value of Proton ascribed by the Proposal. The level of provision will require agreement with the Company's auditors as part of the current audit process. Details of the provision, if any, will be provided in the Company's final results which are expected to be published in October 2023.

 

Richard Parris, Executive Chairman of Sabien, commented:

 

"While it is disappointing to provide for a possible short-term reduction in Proton's equity value, the Board is encouraged by the constructive details of the Proposal. It is clear that Proton requires a larger capital base from which to develop its leading hydrogen technology and we are supportive of the intention to re-balance the business. It remains to be seen as to the outcome of this Proposal, but Sabien is intent on a prudent approach to its balance sheet and the values contained within it."

 

For Further Information:

 

Sabien Technology Group plc

Richard Parris, Executive Chairman

Scott Fulton, Investor Relations 

 

 

 

+44 20 7993 3700

Scott.fulton@sabien.com 

Allenby Capital Limited (Nominated Adviser)

John Depasquale / Nick Harriss / Vivek Bhardwaj 

 

 

+44 203 328 5656

 

Peterhouse Capital Limited (Broker)

Duncan Vasey / Lucy Williams 

 

 

+44 207 469 0930

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLGDCCSDDGXU
Date   Source Headline
1st Oct 20127:00 amRNSPreliminary Statement of Final Results
30th Aug 20122:30 pmRNSRetirement of Chairman
10th Jul 20127:00 amRNSPost Close Trading Statement
7th Mar 20127:00 amRNSRe Contract
7th Feb 20127:00 amRNSHalf Yearly Report
1st Feb 20127:00 amRNSRe-organisation of Nominated Adviser and Broker
12th Jan 201212:20 pmRNSDirector Declaration
12th Jan 20129:27 amRNSCapital Reorganisation
9th Jan 20127:00 amRNSNotice of Results
5th Jan 20127:00 amRNSChange of Adviser
19th Dec 201110:54 amRNSDirector Declaration
29th Nov 201110:19 amRNSHolding(s) in Company
24th Nov 20117:00 amRNSResult of AGM
21st Nov 201110:26 amRNSHolding(s) in Company
17th Nov 201111:23 amRNSHolding(s) in Company
4th Nov 20111:50 pmRNSHolding(s) in Company
1st Nov 20117:00 amRNSAnnual Report and Accounts
7th Oct 20117:00 amRNSNew Contract Win
3rd Oct 20117:00 amRNSFinal Results
12th Sep 20117:00 amRNSNew Contract Win
25th Aug 20117:00 amRNSNew Contract Win
11th Jul 20117:00 amRNSPost Year End Trading Update
29th Jun 20111:12 pmRNSM2G sale to US Distributor
2nd Jun 201112:15 pmRNSNotice of Results
8th Apr 201111:28 amRNSM2G sale to US Distributor
2nd Mar 201111:44 amRNSHolding(s) in Company
1st Mar 201111:08 amRNSHolding(s) in Company
7th Feb 20117:00 amRNSHalf Yearly Report
5th Jan 20117:00 amRNSNotice of Results and Trading Update
26th Nov 20107:00 amRNSDirector/PDMR Shareholding
25th Nov 20107:00 amRNSResult of AGM
17th Nov 20107:00 amRNSAward of Contract
12th Nov 20104:12 pmRNSAnnual Financial Report
29th Oct 20107:00 amRNSPreliminary Results
18th Oct 20107:00 amRNSNotice of Results
15th Oct 20107:00 amRNSDirectorate Change
20th Sep 20107:00 amRNSAward of Contract
6th Aug 20107:00 amRNSAward of Contract
5th Jul 20107:00 amRNSAward of Contract
24th Jun 20107:00 amRNSAward of Contract
1st Jun 20107:00 amRNSTrading Statement
17th May 20107:00 amRNSChange of Adviser
1st Apr 201012:37 pmRNSGrant of options
25th Feb 20107:00 amRNSHalf Yearly Report
2nd Dec 20097:00 amRNSNew Contract Win
9th Nov 20097:00 amRNSAdjustment to number of warrants in issue
28th Oct 20097:00 amRNSPreliminary Results - 12 months ended 30 June 2009
14th Oct 20097:00 amRNSPlacing
7th Oct 20097:00 amRNSContract award
28th Sep 200911:40 amRNSAlliance Agreement with Jones Lang LaSalle

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.